menu
    • menu

    Company profile for SAB Biotherapeutics

    NEW Drugs in Dev: 4
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Modern medicine struggles to keep pace with the emergence, mutation, and diversity of disease. The body’s natural defense system produces polyclonal antibodies against invaders such as viruses, allergens, bacteria, toxins, and other pathogens. SAB Biotherapeutics has developed a first-of-its-kind therapeutic engine—unleashing the power of the body’s native biological defense system to produce immunotherapies that trul...
    Modern medicine struggles to keep pace with the emergence, mutation, and diversity of disease. The body’s natural defense system produces polyclonal antibodies against invaders such as viruses, allergens, bacteria, toxins, and other pathogens. SAB Biotherapeutics has developed a first-of-its-kind therapeutic engine—unleashing the power of the body’s native biological defense system to produce immunotherapies that truly match and overpower the complexity, diversity, and evolution of human disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SAB BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2301 E 60th St N Sioux Falls, SD 57104 844.268.4239
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sabbiotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Emergent BioSolutions Secures Long-Term Manufacturing Deal
    Emergent BioSolutions Secures Long-Term Manufacturing Deal

    29 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/29/3283664/33240/en/emergent-biosolutions-secures-long-term-strategic-manufacturing-contract-with-sab-biotherapeutics-to-advance-type-1-diabetes-candidate-sab-142.html

    GLOBENEWSWIRE
    29 Apr 2026
    Share Share
    SAB Bio Presents SAB-142 Data at 2026 Diabetes Congress
    SAB Bio Presents SAB-142 Data at 2026 Diabetes Congress

    15 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7181781

    FIRSTWORD PHARMA
    15 Apr 2026
    Share Share
    SAB BIO Closes $85M Public Stock Offering And Pre-Funded Warrants
    SAB BIO Closes $85M Public Stock Offering And Pre-Funded Warrants

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259414/0/en/SAB-BIO-Announces-Closing-of-85-Million-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    SAB BIO Announces Common Stock and Pre-Funded Warrants Offering
    SAB BIO Announces Common Stock and Pre-Funded Warrants Offering

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257635/0/en/SAB-BIO-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    SAB Bio Unveils Phase 1 SAB-142 Data in Type 1 Autoimmune Disease
    SAB Bio Unveils Phase 1 SAB-142 Data in Type 1 Autoimmune Disease

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252675/0/en/SAB-BIO-Announces-Additional-Phase-1-Data-for-SAB-142-in-Adult-Patients-with-Established-Autoimmune-Type-1-Diabetes.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    SAB BIO Unveils 2025 Financials And Business Achievements
    SAB BIO Unveils 2025 Financials And Business Achievements

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252356/0/en/SAB-BIO-Reports-Full-Year-2025-Financial-Results-and-Business-Highlights.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search